QA: Enveric Biosciences Inc in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000890821_2024_Enveric_Biosciences_Inc.pdf

Logs

Graph

Absolute values for 0000890821, Enveric Biosciences Inc

  xvar xval
0 AssetsCurrent 3,581,531
1 IntangibleAssetsNetIncludingGoodwill 210,932
2 PropertyPlantAndEquipmentNet 507,377
3 remainder_Assets 0
4 LiabilitiesCurrent 2,343,504
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 3,014,062
8 SellingGeneralAndAdministrativeExpense 3,391,490
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 815,210
11 remainder_Revenues 3,825,767
12 remainder_NetIncome -10,423,363
13 remainder_ComprehensiveNetIncome -200,540
  yvar yval
0 Assets 4,299,840
1 Liabilities 2,343,504
2 Expenses 7,220,762
3 Revenues 3,825,767
4 StockholdersEquity 1,956,336
5 NetIncome -13,818,358
6 ComprehensiveNetIncome -13,918,628
7 BaseVar 14,156,888
8 EconomicCapitalRatiobeforeLimitedLiability -2.91
9 EconomicCapitalRatio 0.718

Edgar->Model Mapping

Feature Distribution

Change over Time